HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Repare Therapeutics (NASDAQ:RPTX) and maintained a $10 price target.
February 21, 2024 | 11:44 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repare Therapeutics maintains a Buy rating and a $10 price target from HC Wainwright & Co., indicating positive analyst sentiment.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. typically signals strong confidence in the company's future performance. This positive sentiment can influence investor perception and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100